Kukje Pharma Co Ltd (002720) — Cash Flow Quality Index

Latest as of September 2025: 2.61x

Kukje Pharma Co Ltd (002720) has a Cash Flow Quality Index of 2.61x as of September 2025. Operating cash flow of ₩4.99 Billion exceeds net income of ₩1.91 Billion, indicating high earnings quality where cash backs reported profits. Explore Kukje Pharma Co Ltd cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

2.61x
Operating CF / Net Income

Operating Cash Flow

₩4.99 Billion
KRW

Net Income

₩1.91 Billion
KRW

Data as of

Sep 2025
Most recent filing

Kukje Pharma Co Ltd Cash Flow Quality Index (2011–2024)

Historical Cash Flow Quality Index for Kukje Pharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002720 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Kukje Pharma Co Ltd (2011–2024)

Year-by-year earnings quality comparison for Kukje Pharma Co Ltd. For live market cap and the full company financial profile, see 002720 company net worth.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2024 0.76x ₩3.94 Billion ₩5.21 Billion ▼ -58.6%
2022 1.83x ₩6.50 Billion ₩3.56 Billion ▼ -21.0%
2020 2.32x ₩5.10 Billion ₩2.20 Billion ▼ -61.7%
2018 6.04x ₩13.25 Billion ₩2.19 Billion ▲ +739.6%
2017 0.72x ₩786.10 Million ₩1.09 Billion ▼ -96.5%
2016 20.82x ₩16.10 Billion ₩773.06 Million ▲ +857.6%
2013 -2.75x ₩-4.60 Billion ₩1.67 Billion ▼ -114.7%
2011 18.74x ₩17.39 Billion ₩927.81 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.